Progressive
Care Inc. Garners Coverage in Publicly Traded
Podcasts
MIAMI, FL -- July 18, 2019 -- InvestorsHub NewsWire
-- Progressive
Care Inc. (OTCQB: RXMD), a personalized
healthcare services and technology company, today announced that it
has garnered media coverage in
Publicly Traded Podcasts's Health Highlights.
"I am proud to
share the success of Progressive Care with Publicly Traded Podcasts
and their audience," said S. Parikh Mars, CEO of Progressive Care
Inc. "As our company continues to grow, it is important to look
back on our success on how we've gotten to where we are today. We
are excited to see what the rest of 2019 brings us."
In
the podcast titled
RXMD - Ms. Shital Mars
(OTCQB: RXMD),
published July 11, 2019 on Publicly Traded Podcasts, Mars talks in
detail about recent record-breaking sales in April, the acquisition
of Family Physicians RX, and positioning the company for a solid
finish to 2019. Mars says, "What we've really focused on is turning
this company into a solid healthcare-driven enterprise that focuses
on the future, focuses on technology, focuses on innovation and
patient care. I think that has shown why we've been so successful
over the last 3 or 4 years since I've been involved at the
helm."
In
the article, Mars goes on to discuss what fueled the dynamic growth
and record-breaking sales from April. "What comes out every year
are what is called HEDIS
scores.
A lot of doctors get these performance ratings that tell them how
well they're performing within the pan and managing their patients'
outcomes.
40%
of that performance score is tied to the performance of the
pharmacy. So if a patient goes to the doctor and then never fills
their prescription for chronic care conditions like diabetes, that
doctor is going to underperform because the pharmacy is not filling
those prescriptions. When these scores come out, they start
recognizing that they have improvement that they need to make. A
lot of that improvement centers on pharmaceutical care so they
begin to look for the best pharmacies in their area…. When I say
that we are a 5-star pharmacy, that means that we are proactive at
working with the patient… We are constantly getting new
prescriptions,
constantly getting new patients, and constantly on-boarding new
physicians who are looking for this level of care because it makes
a difference for their practice and patients. So that's really what
fuels a lot of this growth."
Mars
goes on to discuss the acquisition of Family Physicians RX. "We
have a number of accomplishments that have occurred over the last
three years. The acquisition of Family Physicians RX is our biggest
one, it's the one that I am most proud of. It's something that we
have been preparing for many years. What it did for us was allow us
to effectively double in size. They do about 18,000 prescriptions a
month, so that brings us as a combined entity close to 50,000
prescriptions a month out of all of our stores. They do $1.4
million a month in net revenue so that brings us close to about $3
million a month in revenue. It took us from two locations to four.
It brought us from South Florida now to Orlando."
The recent media
coverage comes after the company's efforts to provide its network
with more healthcare informational resources through
PharmCo
Pharmacy.
Additional commentary from Progressive Care's CEO about the company
and industry as a whole can be found on the Progressive
Care blog and PharmCo
blog.
For more
immediate updates on the company's media coverage, connect with
Progressive Care and PharmCo on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals, compounded medications,
provider of tele-pharmacy services, the sale of anti-retroviral
medications, medication therapy management (MTM), the supply of
prescription medications to long-term care facilities, and health
practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Public
Relations Contact:
Kathleen
Gonzales, CMW Media
kathleen@cmwmedia.com
www.cmwmedia.com
Investor
Relations Contact:
Armen Karapetyan,
Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2024 to May 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From May 2023 to May 2024